ONCY (STOCKS)
Oncolytics Biotech, Inc. Common Shares
$0.944000
+0.012200 (+1.31%)
Prev close: $0.931800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jared Kelly
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $113.36M
- Employees
- 28
- P/E (TTM)
- -3.81
- P/B (TTM)
- -21.73
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $32.99M |
| Research and Development | $15.07M |
| Other Operating Expenses | $17.92M |
| Operating Income/Loss | -$32.99M |
| Income/Loss From Continuing Operations After Tax | -$33.29M |
| Income/Loss From Continuing Operations Before Tax | -$33.21M |
| Net Income/Loss | -$33.29M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$33.29M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.29M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.32 |
| Diluted Earnings Per Share | -$0.32 |
| Basic Average Shares | 123,518,281 |
| Diluted Average Shares | 123,518,281 |
| Assets | $8.16M |
| Current Assets | $7.49M |
| Prepaid Expenses | $1.03M |
| Other Current Assets | $6.45M |
| Noncurrent Assets | $674.00K |
| Fixed Assets | $218.00K |
| Other Non-current Assets | $456.00K |
| Liabilities | $13.29M |
| Current Liabilities | $5.42M |
| Accounts Payable | $2.68M |
| Other Current Liabilities | $2.74M |
| Noncurrent Liabilities | $7.87M |
| Equity | -$5.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$5.13M |
| Liabilities And Equity | $8.16M |
| Net Cash Flow From Operating Activities | -$22.67M |
| Net Cash Flow From Operating Activities, Continuing | -$22.67M |
| Net Cash Flow From Investing Activities | -$11.00K |
| Net Cash Flow From Investing Activities, Continuing | -$11.00K |
| Net Cash Flow From Financing Activities | $17.55M |
| Net Cash Flow From Financing Activities, Continuing | $17.55M |
| Exchange Gains/Losses | -$20.00K |
| Net Cash Flow | -$5.15M |
| Net Cash Flow, Continuing | -$5.13M |
| Comprehensive Income/Loss | -$33.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.54M |
| Other Comprehensive Income/Loss | -$33.54M |